The Indianapolis-Ibadan Dementia Project has now demonstrated that incidence rates for Alzheimer disease (AD) and dementia are significantly lower in Yoruba than in African Americans. In our new application we are proposing to study intensively risk factors which may explain the differences in incidence rates. As these risk factors are likely to be multiple, complex, involving genetic, environmental as well as genetic-environmental interactive influences, larger cohorts than those we currently possess will be required. We propose to enrich our current surviving cohort of 800 subjects in each site by recruiting an additional 2000 African Americans and 2000 Yoruba, 70 years and over, for a total of 2800 subjects at each site. With this enlarged sample we propose to measure ApoE genotypes and ApoE promoter haplotypes on all subjects in both cohorts. As exploration of site differences suggest that factors associated with increased vascular risk may be a productive line of investigation, we will also measure a number of biochemical values known to be associated with cardiovascular risk. We will continue to collect our current clinical, neuropsychological and socio-demographic data. With these new data we propose to test the following hypotheses. 1) Possession of the e4 allele of ApoE will be a stronger risk factor for AD in African Americans than in the Yoruba. The ApoE 2 allele will be protective for AD in the African Americans but not in the Yoruba. 2) Vascular risk factors increase the risk of dementia, AD and cognitive decline within each population site. The lower prevalence of these factors accounts for some of the differences in rates of AD and dementia between sites. 3) The interaction between ApoE genotypes and vascular risk factors alter the strength of the association between the ApoE 4 and 2 alleles and AD and account for some of the variation in AD rates between the populations. Our secondary aims are, 1) to continue to develop measurements of social engagement and activity levels which can be applied validly across sites; 2) to continue to evaluate natural history of cognitive and social functioning in two community-dwelling cohorts and to identify factors which may predict decline in cognitive and social function; 3) to determine if ApoE promoter haplotype is a risk factor for AD and correlate this risk with promoter transcriptional activity; and 4) to store blood, plasma and DNA samples for future genetic and biological studies.

National Institute of Health (NIH)
National Institute on Aging (NIA)
Research Project (R01)
Project #
Application #
Study Section
Epidemiology and Disease Control Subcommittee 2 (EDC)
Program Officer
Anderson, Dallas
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Indiana University-Purdue University at Indianapolis
Schools of Medicine
United States
Zip Code
Campbell, Noll L; Lane, Kathleen A; Gao, Sujuan et al. (2018) Anticholinergics Influence Transition from Normal Cognition to Mild Cognitive Impairment in Older Adults in Primary Care. Pharmacotherapy 38:511-519
Mez, Jesse; Chung, Jaeyoon; Jun, Gyungah et al. (2017) Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans. Alzheimers Dement 13:119-129
Gao, Sujuan; Ogunniyi, Adesola; Hall, Kathleen S et al. (2016) Dementia incidence declined in African-Americans but not in Yoruba. Alzheimers Dement 12:244-51
Hohman, Timothy J; Cooke-Bailey, Jessica N; Reitz, Christiane et al. (2016) Global and local ancestry in African-Americans: Implications for Alzheimer's disease risk. Alzheimers Dement 12:233-43
Kim, Sungeun; Nho, Kwangsik; Ramanan, Vijay K et al. (2016) Genetic Influences on Plasma Homocysteine Levels in African Americans and Yoruba Nigerians. J Alzheimers Dis 49:991-1003
Ghani, Mahdi; Reitz, Christiane; Cheng, Rong et al. (2015) Association of Long Runs of Homozygosity With Alzheimer Disease Among African American Individuals. JAMA Neurol 72:1313-23
Jin, Sheng Chih; Carrasquillo, Minerva M; Benitez, Bruno A et al. (2015) TREM2 is associated with increased risk for Alzheimer's disease in African Americans. Mol Neurodegener 10:19
Hendrie, Hugh C; Hake, Ann; Lane, Kathleen et al. (2015) Statin Use, Incident Dementia and Alzheimer Disease in Elderly African Americans. Ethn Dis 25:345-54
Clark, Daniel O; Gao, Sujuan; Lane, Kathleen A et al. (2014) Obesity and 10-year mortality in very old African Americans and Yoruba-Nigerians: exploring the obesity paradox. J Gerontol A Biol Sci Med Sci 69:1162-9
Hendrie, Hugh C; Murrell, Jill; Baiyewu, Olusegun et al. (2014) APOE ?4 and the risk for Alzheimer disease and cognitive decline in African Americans and Yoruba. Int Psychogeriatr 26:977-85

Showing the most recent 10 out of 93 publications